Rich Nazarian chooses his words carefully when explaining his company's foray into turning its own ideas into medical technology.
"We have no intention of being in competition with our customers," he said. "We really intend to be complimentary to what they do."
Nonetheless, the St. Paul-based medical technology design and manufacture firm is walking a bit of a tightrope. Minnetronix, begun in 1996, has made its name in working fast and well for others, leading 150 design and manufacturing projects for more than 100 companies, including corporate giants such as 3M, Medtronic and St. Jude Medical. But in June, it announced plans to start developing its own intellectual property.
The risk, Nazarian's assurances notwithstanding, is that one of its longtime customers will see the move as a threat. Officials for Medtronic and St. Jude declined to comment for this story. But Nazarian said he is convinced Minnetronix can continue its core business while venturing into new products and technologies of its own design. The trick, he said, will be to develop products that might not otherwise have been built.
"We want to build a portfolio of devices that are attractive to our customers," said Nazarian, company president and CEO.
Minnetronix didn't get into specifics about the products it would make.
Recognizing the gaps
One reason for developing its own intellectual property is simple enough: money. Minnetronix, a private company with nearly 200 employees that include 70 engineers, has developed dozens of patents over the years. Etched into metal plaques, the patents make for an impressive display on a corridor wall at Minnetronix headquarters in St. Paul's Energy Park.